Journal Home
Search for

Volume 37, Issue 4, Pages 412-420 (December 2009)


View previous. 14 of 18 View next.

Developing an integrated treatment for substance use and depression using cognitive–behavioral therapy

Karen Chan Osilla, Ph.D.aCorresponding Author Informationemail address, Kimberly A. Hepner, Ph.D.a, Ricardo F. Muñoz, Ph.D.b, Stephanie Woo, Ph.D.c, Katherine Watkins, M.D., M.S.H.S.a

Received 3 April 2009; accepted 28 April 2009. published online 22 June 2009.

Abstract 

Providing a unified treatment approach to meet the substance abuse and mental health needs of clients is the preferred model for addressing co-occurring disorders. We developed a group-based cognitive-behavioral (CBT) integrated treatment for depression and substance use disorders (SUD) that could be delivered by counselors in SUD treatment settings and evaluated its feasibility and acceptability. We conducted an in-depth case study examining one implementation of the treatment using 15 focus groups with clients (n = 7) and semistructured interviews with counselors (n = 2) and administrators (n = 3). Using CBT as a treatment approach to integrate the treatment was widely accepted by clients, counselors, and administrators. Clients stated the treatment was applicable to multiple aspects of their lives and allowed them to recognize their clinical improvements over time. Counselors and administrators discussed challenges for long-term feasibility. Key decisions used to develop the treatment and recommendations for implementing integrated care in SUD settings are discussed.

a RAND Corporation, PO Box 2138, Santa Monica, CA 90407-2138, USA

b University of California, San Francisco/San Francisco General Hospital, 1001 Potrero Avenue, Suite 7M, San Francisco, CA 94110, USA

c Pepperdine University Graduate School of Education & Psychology, 24255 Pacific Coast Highway, Malibu, CA 90263-4608, USA

Corresponding Author InformationCorresponding author. RAND Corporation, PO Box 2138, Santa Monica, CA 90407, USA. Tel.: +1 310 393 0411x6074; fax: +1 310 260 8150.

PII: S0740-5472(09)00067-1

doi:10.1016/j.jsat.2009.04.006


View previous. 14 of 18 View next.